Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis
We read with great interest the article by Hanauer et al.1 Their study showed that tofacitinib induction therapy for ulcerative colitis results in a rapid clinical response. We recently used tofacitinib and infliximab as combination rescue therapy to avoid colectomy in a hospitalized patient with severe ulcerative colitis. We also observed a very rap id onset of action.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Nadia Griller, Lawrence Cohen Tags: Letter to the Editor Source Type: research
More News: Colectomy | Gastroenterology | Inflammatory Bowel Disease | Legislation | Remicade | Study | Ulcerative Colitis